Crescent Specialty Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
- Paid Up Capital ₹ 0.79 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 102.39%
- Profit Growth -42.72%
- Ebitda -315.70%
- Net Worth 0.42%
- Total Assets 0.32%
About Crescent Specialty Chemicals
Crescent Specialty Chemicals Private Limited (CSCPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2011 and has a history of 13 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 0.79 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Vaidya and Kumbhare Anil serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2011PTC223933
-
Company No.
223933
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Crescent Specialty Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Vaidya
|
Director | 05-Jan-2017 | Current |
|
Kumbhare Anil
|
Director | 12-Dec-2022 | Current |
Financial Performance of Crescent Specialty Chemicals.
Crescent Specialty Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 102.39% increase. The company also saw a substantial fall in profitability, with a 42.72% decrease in profit. The company's net worth moved up by a moderate rise of 0.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crescent Specialty Chemicals?
In 2023, Crescent Specialty Chemicals had a public holding of 52.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Trigon Antioxidants Private LimitedRavindra Vaidya is a mutual person
-
Reach Perfection Ventures LlpKumbhare Anil is a mutual person
-
Augustus Realty Venturez Llp
Kumbhare Anil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crescent Specialty Chemicals?
Unlock and access historical data on people associated with Crescent Specialty Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crescent Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Specialty Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
